BOS
MANCHESTER
2023
Programme
Speakers
Attendees
Sponsors
Adverts
Partnering
Location
Register
LOGIN
Login
Forgot Password
Speaker
Select...
Aleksandra Singh
Alissa Monk
Andrew Stark
Anthony Fuller
Brian Cox
Calum Cook
Colm Campbell
Craig S. Harris
Dave Ennis
Donald Charles Ross
Dr Vijayavitthal Mathad
Duncan Judd
Farid Khan
George Taylor
Iain MacGilp
Jan Haller
Jenifer Mains
Joan Herbert
Kreshnik Hoxha
Magdalena Kierkowicz
Mark Lawlor
Paul Madeley
Paul Varley
Paul Willis
Scott Webster
Scott Wharry
Shane McKenna
Stella James
Stephane Hauduc
Suzanne Dilly
Thorsten Nowak
OR Category
Select...
CMC
Discovery
CMC: Small Molecules
CMC: Biologics
CMC: Biologics, Drug Substance
CMC: Biologics, Drug Product
CMC: Biologics, Analytical
CMC: Biologics, Drug Delivery
CMC: Biologics, Packaging
CMC: Small Molecules, Drug Substance
CMC: Small Molecules, Drug Product
CMC: Small Molecules, Analytical
CMC: Small Molecules, Drug Delivery
CMC: Small Molecules, Packaging
Discovery: Target Discovery
Discovery: Discovery Chemistry
Discovery: Discovery Biology
Discovery: DMPK
Speakers
Dr Aleksandra Singh
R&D Oligonucleotide Synthesis Team Leader, Sixfold Bioscience
Miss Alissa Monk
Sustainability Lead, ten23 health
Mr Andrew Stark
Senior Scientist, Astrazeneca
Mr Anthony Fuller
Global Head of Sourcing, Mitsubishi Tanabe
Prof Brian Cox
Emeritus Professor of Pharmaceutical Chemistry, B Cox Consulting Ltd
Mr Calum Cook
Lead Technical Outsourcing Manager, AstraZeneca
Dr Colm Campbell
Senior Director, Chemical Development & Manufacturing, BioMarin
Dr Craig S. Harris
CEO and Founder, CMC Innov Consulting
Dr Dave Ennis
VP Environmental Protection, AstraZeneca
Mr Donald Charles Ross
Life Sciences Leader, CRAMSN Research Park Private Limited
Mr Dr Vijayavitthal Mathad
Chief Operating Officer, CRAMSN Research Park Private Limited
Mr Duncan Judd
Director, Awridian Ltd
Dr Farid Khan
CEO, Pharmakure Ltd
Mr George Taylor
Chemistry Team Leader, Sai Life Sciences Limited
Dr Iain MacGilp
Senior Director, Curia Scotland Ltd
Dr Jan Haller
R&D-Chemist, Axplora
Dr Jenifer Mains
Director Formulation Science, Bicycle Therapeutics
Dr Joan Herbert
Vice President, Business Development, Medicines for Malaria Venture
Dr Kreshnik Hoxha
Director of CMC and Clinical Supply Chain, Grey Wolf Therapeutics
Dr Magdalena Kierkowicz
Senior Scientist, UCB Pharma Ltd
Dr. Mark Lawlor
Vice-President, Product Development, Pharmaron
Dr Paul Madeley
Managing Director,
[email protected]
Dr Paul Varley
VP CMC Development, Alchemab
Dr Paul Willis
Senior Director, MMV
Prof Scott Webster
Chief Technology Officer, Kynos Therapeutics Ltd
Dr Scott Wharry
Custom and Flow Chemistry Manager, Almac
Dr Shane McKenna
Principal Scientist, Bristol-Myers Squibb
Dr Stella James
Executive Director Business Development, Bionow
Mr Stephane Hauduc
Senior CMC Project and IP Manager, Destiny Pharma plc
Dr Suzanne Dilly
CEO, ValiRx PLC
Dr Thorsten Nowak
VP, Medicinal Chemistry, Exscientia
